1. Therapeutic Potential Of Human Neural Precursor Cells in Diabetic Retinopathy – Preclinical Model
- Author
-
Sato M, Moreno J, Abdelwahid E, Stricker Pef, Dziedzic Dsm, Maiara Carolina Perussolo, Montiani-Ferreira F, Saçaki Cs, Carvalho K.A.T K, Noronha L, Franco Crc, Bacellar-Galdino M, Ana Carolina Irioda, Dornbusch P, Bassam Felipe Mogharbel, Nagashima S, and Shiokawa N
- Subjects
Text mining ,business.industry ,allergology ,Precursor cell ,Mesenchymal stem cell ,Cancer research ,Medicine ,Diabetic retinopathy ,Stem cell ,business ,medicine.disease - Abstract
This study aimed to evaluate cell therapy with human neural precursor cells (hNPCs) in diabetic retinopathy (DR) Wistar rats, induced to diabetes by intraperitoneal injection with streptozotocin. Wharton's Jelly Mesenchymal stem cells (WJ-MSCs) were isolated, expanded, and seeded onto a biopolymer substrate without growth factors to develop neurospheres to obtain the hNPCs, characterized by immunocytochemistry. The animals were divided into three groups; non-diabetic (ND) n = four; diabetic without treatment (DM) n = nine; and diabetic with cell therapy (DM + hNPCs) n = nine. After eight weeks of diabetes induction and verified DR, intravitreal injection of hNPCs (1 x 106 cel/µL) was performed in the DM + hNPCs group. Optical Coherence Tomography (OCT) and Electroretinography (ERG) evaluations were done before and after diabetes induction and after cell therapy. Eye enucleation occurred four weeks after treatment for the histopathological and immunohistochemistry analyses. In the treated group, there was the repair of the retinal structures and their arrangements. hNPCs increased the thickness of neuroretina layers, especially in the ganglion cell and photoreceptor layers. The results indicate that hNPCs reduced DR progression by a neuroprotective effect and promoted retinal repair, making them potential candidates for regeneration of the neuroretinal tissue.
- Published
- 2021
- Full Text
- View/download PDF